COVID-19 vaccine safety update for COVID-19 Vaccine Janssen: 14 July 2021

Signal assessment report on embolic and thrombotic events (SMQ) with COVID-19 Vaccine Janssen (Ad26.COV2-S [recombinant]) adopted at PRAC meeting 3-6 May 2021

COVID-19 vaccine safety update for COVID-19 Vaccine Janssen: 11 May 2021

Signal assessment report on embolic and thrombotic events (SMQ) with COVID-19 Vaccine Janssen (Ad26.COV2-S [recombinant]) adopted at PRAC meeting 20 April 2021

Human medicines European public assessment report (EPAR): Nexviadyme, Avalglucosidase alfa, Date of authorisation: 24/06/2022, Revision: 5, Status: Authorised

Contact details of national competent authorities for requests to use a sticker to place the Unique Identifier on the outer/immediate packaging of centrally approved products

Member states contact points for review of national versions of the content of mobile scanning and other technologies

Contact details of national competent authorities for requests of translation exemptions falling under Art. 63.3 of Directive 2001/83/EC and cases of shortages

Human medicines European public assessment report (EPAR): Avzivi, bevacizumab, Date of authorisation: 26/07/2024, Status: Authorised

Veterinary pre-submission meeting request form - in accordance with Regulation (EU) No 2019/6